Skip to content
Menu

Benitec Biopharma Q1 EPS $(0.26) Beats $(0.29) Estimate

Benzinga Newsdesk 1 week ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.29) by 10.34 percent. This is a 18.18 percent decrease over losses of $(0.22) per share

Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.29) by 10.34 percent. This is a 18.18 percent decrease over losses of $(0.22) per share from the same period last year.

Read at benzinga.com

← All stock news